|
| 36735908 | Predictive value of staging PET/CT to detect bone marrow involvement and early outcomes in marginal zone lymphoma. | Blood | 2023 |
| 37957158 | Evolving treatment patterns and improved outcomes in relapsed/refractory mantle cell lymphoma: a prospective cohort study. | Blood Cancer J | 2023 |
| 37254453 | Molecular classification and identification of an aggressive signature in low-grade B-cell lymphomas. | Hematol Oncol | 2023 |
| 36709663 | Results of TRIO-15, a multicenter, open-label, phase II study of the efficacy and safety of ganitumab in patients with recurrent platinum-sensitive ovarian cancer. | Gynecol Oncol | 2023 |
| 36639731 | Diagnostic and prognostic potential of the microbiome in ovarian cancer treatment response. | Sci Rep | 2023 |
| 34662895 | Evolving frontline immunochemotherapy for mantle cell lymphoma and the impact on survival outcomes. | Blood Adv | 2022 |
| 35580285 | Patient Experience in Clinical Trials: Quality of Life, Financial Burden, and Perception of Care in Patients With Multiple Myeloma or Lymphoma Enrolled on Clinical Trials Compared With Standard Care. | JCO Oncol Pract | 2022 |
| 35472731 | Machine-learning aided in situ drug sensitivity screening predicts treatment outcomes in ovarian PDX tumors. | Transl Oncol | 2022 |
| 35594505 | Long-Term Health-Related Quality of Life of Autologous Hematopoietic Cell Transplantation Patients and Nontransplant Patients With Aggressive Lymphoma: A Prospective Cohort Analysis. | JCO Oncol Pract | 2022 |
| 35358443 | Treatment patterns and outcomes of patients with relapsed or refractory follicular lymphoma receiving three or more lines of systemic therapy (LEO CReWE): a multicentre cohort study. | Lancet Haematol | 2022 |
| 36057138 | Revised MALT-IPI: A new predictive model that identifies high-risk patients with extranodal marginal zone lymphoma. | Am J Hematol | 2022 |
| 34810199 | Repurposing Ceritinib Induces DNA Damage and Enhances PARP Inhibitor Responses in High-Grade Serous Ovarian Carcinoma. | Cancer Res | 2022 |
| 34782394 | Vaccination History and Risk of Lymphoma and Its Major Subtypes. | Cancer Epidemiol Biomarkers Prev | 2022 |
| 32139889 | Targeting of inflammatory pathways with R2CHOP in high-risk DLBCL. | Leukemia | 2021 |
| 33850213 | Statistical analysis of comparative tumor growth repeated measures experiments in the ovarian cancer patient derived xenograft (PDX) setting. | Sci Rep | 2021 |
| 33644854 | Aspirin and other nonsteroidal anti-inflammatory drugs, statins and risk of non-Hodgkin lymphoma. | Int J Cancer | 2021 |
| 33657788 | The significance of gradient expression of chromosome region maintenance protein 1 (exportin1) in large cell lymphoma. | Haematologica | 2021 |
| 34885153 | CHFR and Paclitaxel Sensitivity of Ovarian Cancer. | Cancers (Basel) | 2021 |
| 35028612 | Multiomic analysis identifies CPT1A as a potential therapeutic target in platinum-refractory, high-grade serous ovarian cancer. | Cell Rep Med | 2021 |
| 34121594 | Body mass index and survival of patients with lymphoma. | Leuk Lymphoma | 2021 |
| 34267181 | Lack of intrafollicular memory CD4â¿¿+â¿¿T cells is predictive of early clinical failure in newly diagnosed follicular lymphoma. | Blood Cancer J | 2021 |
| 34162658 | Identification of a Locus Near <i>ULK1</i> Associated With Progression-Free Survival in Ovarian Cancer. | Cancer Epidemiol Biomarkers Prev | 2021 |
| 33971040 | Anthracycline treatment, cardiovascular risk factors and the cumulative incidence of cardiovascular disease in a cohort of newly diagnosed lymphoma patients from the modern treatment era. | Am J Hematol | 2021 |
| 33047636 | The association of health behaviors with quality of life in lymphoma survivors. | Leuk Lymphoma | 2021 |
| 32800727 | Two-stage Study of Familial Prostate Cancer by Whole-exome Sequencing and Custom Capture Identifies 10 Novel Genes Associated with the Risk of Prostate Cancer. | Eur Urol | 2021 |
| 32473302 | Prognostic gene expression signature for high-grade serous ovarian cancer. | Ann Oncol | 2020 |
| 31671178 | Human Pegivirus Infection and Lymphoma Risk: A Systematic Review and Meta-analysis. | Clin Infect Dis | 2020 |
| 31897876 | Compliance with cancer screening and influenza vaccination guidelines in non-Hodgkin lymphoma survivors. | J Cancer Surviv | 2020 |
| 31797631 | Coverage profile correction of shallow-depth circulating cell-free DNA sequencing via multidistance learning. | Pac Symp Biocomput | 2020 |
| 33168821 | Somatic copy number gains in MYC, BCL2, and BCL6 identifies a subset of aggressive alternative-DH/TH DLBCL patients. | Blood Cancer J | 2020 |
| 32554541 | Development and Validation of the Gene Expression Predictor of High-grade Serous Ovarian Carcinoma Molecular SubTYPE (PrOTYPE). | Clin Cancer Res | 2020 |
| 30474261 | Prevalence, clinical characteristics and prognosis of EBV-positive follicular lymphoma. | Am J Hematol | 2019 |
| 30165169 | Comparison of tumor staging systems for cutaneous squamous cell carcinoma in patients with chronic lymphocytic leukemia. | J Am Acad Dermatol | 2019 |
| 31239549 | A combination of the immunohistochemical markers CK7 and SATB2 is highly sensitive and specific for distinguishing primary ovarian mucinous tumors from colorectal and appendiceal metastases. | Mod Pathol | 2019 |
| 31292113 | Developmental subtypes assessed by DNA methylation-iPLEX forecast the natural history of chronic lymphocytic leukemia. | Blood | 2019 |
| 30916801 | The utility of prognostic indices, early events, and histological subtypes on predicting outcomes in non-follicular indolent B-cell lymphomas. | Am J Hematol | 2019 |
| 31001917 | Evaluation of vitamin D biosynthesis and pathway target genes reveals UGT2A1/2 and EGFR polymorphisms associated with epithelial ovarian cancer in African American Women. | Cancer Med | 2019 |
| 31135975 | Impact of metformin use on the outcomes of newly diagnosed diffuse large B-cell lymphoma and follicular lymphoma. | Br J Haematol | 2019 |
| 31170029 | Late Relapses in Patients With Diffuse Large B-Cell Lymphoma Treated With Immunochemotherapy. | J Clin Oncol | 2019 |
| 30958860 | An expanded variant list and assembly annotation identifies multiple novel coding and noncoding genes for prostate cancer risk using a normal prostate tissue eQTL data set. | PLoS One | 2019 |
| 30576442 | Molecular signatures of X chromosome inactivation and associations with clinical outcomes in epithelial ovarian cancer. | Hum Mol Genet | 2019 |
| 29434467 | Genomic Analysis Using Regularized Regression in High-Grade Serous Ovarian Cancer. | Cancer Inform | 2018 |
| 29808922 | Human Pegivirus infection and lymphoma risk and prognosis: a North American study. | Br J Haematol | 2018 |
| 30230581 | The association of physical activity before and after lymphoma diagnosis with survival outcomes. | Am J Hematol | 2018 |
| 30117139 | Autoimmune cytopenias in patients with chronic lymphocytic leukaemia treated with ibrutinib in routine clinical practice at an academic medical centre. | Br J Haematol | 2018 |
| 30062862 | Association of p16 expression with prognosis varies across ovarian carcinoma histotypes: an Ovarian Tumor Tissue Analysis consortium study. | J Pathol Clin Res | 2018 |
| 29419435 | Outcomes of a large cohort of individuals with clinically ascertained high-count monoclonal B-cell lymphocytosis. | Haematologica | 2018 |
| 27916600 | Mapping Complex Traits in a Diversity Outbred F1 Mouse Population Identifies Germline Modifiers of Metastasis in Human Prostate Cancer. | Cell Syst | 2017 |
| 28346442 | Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer. | Nat Genet | 2017 |
| 29156765 | Network-directed cis-mediator analysis of normal prostate tissue expression profiles reveals downstream regulatory associations of prostate cancer susceptibility loci. | Oncotarget | 2017 |